XTL Biopharmaceuticals Ltd Long-term Investment Intensity
XTL Biopharmaceuticals Ltd long-term investment intensity. XTL Biopharmaceuticals Ltd (H2K2) has a Long-term Investment Intensity of 0.2% as of December 2024. Long-term investments of €14.00K represent 0.2% of total assets of €8.55 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read XTL Biopharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of XTL Biopharmaceuticals Ltd (2024–2024)
Long-term investment intensity of XTL Biopharmaceuticals Ltd from 2024 to 2024. This chart shows how XTL Biopharmaceuticals Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 0.2%, reflecting long-term investments of €14.00K against total assets of €8.55 Million EUR.
XTL Biopharmaceuticals Ltd Long-term Investment Intensity by Year (2024–2024)
XTL Biopharmaceuticals Ltd long-term investment intensity by year from 2024 to 2024. The table below presents the year-by-year Long-term Investment Intensity for XTL Biopharmaceuticals Ltd from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see XTL Biopharmaceuticals Ltd (H2K2) total assets.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.2% | €14.00K | €8.55 Million | — |